After treatment, the expression level of Ki-67 in the LY, CUR and COM group decreased by 17.27% (p < 0.05), 22.47% (p < 0.05) and 29.13% (p < 0.01), respectively, compared with the BPH group. Here, MKI67 is linked to benign prostatic hyperplasia.